Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
--
Revenue (TTM)
--
Net Profit (TTM)
--
ROE
--
ROCE
--
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
EV/EBITDA
--
Div. Yield
--
Debt to Equity
--
Book Value
--
EPS
--
Face value
--
Shares outstanding
--
CFO
$-21.54 Mln
EBITDA
$-31.57 Mln
Net Profit
$-16.50 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sharps Technology Inc. Warrant (STSSW)
| -42.2 | 55.3 | -16.5 | -80.3 | -60.7 | -- | -- |
|
BSE Sensex
| 3.7 | -1.6 | 9.6 | 5.9 | 14.3 | 19.1 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe... products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York. Address: 105 Maxess Road, Melville, NY, United States, 11747 Read more
CEO & Director
Mr. Robert M. Hayes
CEO & Director
Mr. Robert M. Hayes
Headquarters
Melville, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Sharps Technology Inc Warrant (STSSW) is $0.02 (NASDAQ) as of 13-Jun-2025 11:08 EDT. Sharps Technology Inc Warrant (STSSW) has given a return of -60.72% in the last 3 years.
Sharps Technology Inc Warrant (STSSW) has a market capitalisation of -- as on 12-Jun-2025. As per Value Research classification, it is a Small Cap company.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Sharps Technology Inc Warrant (STSSW) and enter the required number of quantities and click on buy to purchase the shares of Sharps Technology Inc Warrant (STSSW).
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York. Address: 105 Maxess Road, Melville, NY, United States, 11747
The CEO & director of Mr. Robert M. Hayes. is Sharps Technology Inc Warrant (STSSW), and CFO & Sr. VP is Mr. Robert M. Hayes.
There is no promoter pledging in Sharps Technology Inc Warrant (STSSW).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Sharps Technology Inc. Warrant (STSSW) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Sharps Technology Inc Warrant (STSSW) was $0 Mln.
$0.00
(
